Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin (2016 - 2025)

Historic EBT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to 7.06%.

  • Mesa Laboratories' EBT Margin rose 105900.0% to 7.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 5.68%, marking a year-over-year increase of 1191800.0%. This contributed to the annual value of 2.47% for FY2025, which is 1299800.0% up from last year.
  • Mesa Laboratories' EBT Margin amounted to 7.06% in Q4 2025, which was up 105900.0% from 3.29% recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' EBT Margin registered a high of 12.89% during Q1 2021, and its lowest value of 467.42% during Q1 2024.
  • Its 5-year average for EBT Margin is 20.61%, with a median of 3.41% in 2022.
  • In the last 5 years, Mesa Laboratories' EBT Margin tumbled by -4669300bps in 2024 and then soared by 4681700bps in 2025.
  • Over the past 5 years, Mesa Laboratories' EBT Margin (Quarter) stood at 4.28% in 2021, then skyrocketed by 182bps to 3.53% in 2022, then increased by 3bps to 3.64% in 2023, then crashed by -197bps to 3.53% in 2024, then surged by 300bps to 7.06% in 2025.
  • Its last three reported values are 7.06% in Q4 2025, 3.29% for Q3 2025, and 11.78% during Q2 2025.